{"entities":{"Q101301":{"pageid":102621,"ns":120,"title":"Item:Q101301","lastrevid":59506374,"modified":"2026-04-10T12:55:18Z","type":"item","id":"Q101301","labels":{"en":{"language":"en","value":"Optimal curtailed designs for single arm phase II clinical trials"}},"descriptions":{"en":{"language":"en","value":"scientific article from arXiv"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q101301$8AF33100-9C96-483E-935C-4A12C186250E","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"f8e370209c973d3f707f42076c8c7b30a65496a2","datavalue":{"value":{"time":"+2019-09-06T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q101301$76814FB5-E9E3-4F67-A986-6E28EEA0C78F","rank":"normal"}],"P21":[{"mainsnak":{"snaktype":"value","property":"P21","hash":"4af391266cccdeebc0a5ff6f5bff228a37530745","datavalue":{"value":"1909.03017","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q101301$F20DA96D-6632-4F77-8726-C885E785FA66","rank":"normal"}],"P22":[{"mainsnak":{"snaktype":"value","property":"P22","hash":"cfb7e6a31ecd9ade930a066df193bc613d5886e7","datavalue":{"value":"stat.ME","type":"string"},"datatype":"string"},"type":"statement","id":"Q101301$4F9F0A3A-44AE-4616-9523-68C1E3190C34","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P22","hash":"7e870ff8897be33da13b5d155d223b923bd3a505","datavalue":{"value":"stat.AP","type":"string"},"datatype":"string"},"type":"statement","id":"Q101301$8685985C-6D5F-4202-AAAE-93A5B876EF08","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"eef5b27f09620513637efeba880345caefeb8ce6","datavalue":{"value":{"entity-type":"item","numeric-id":101297,"id":"Q101297"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q101301$797AF002-6E48-4ED3-B01F-E4C7C90EAF03","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"8de64e74c8c3791d0951b8a854487a7dabecefbc","datavalue":{"value":{"entity-type":"item","numeric-id":101298,"id":"Q101298"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q101301$C6FFA333-2035-4183-AA5F-61060C86AB27","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"23c5d012cacba9579fcb492d8669244f6f9ed26f","datavalue":{"value":{"entity-type":"item","numeric-id":101299,"id":"Q101299"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q101301$ED28FD95-1A99-4C86-B0F5-24659B4B8177","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q101301$A40A8474-1BB4-4D81-80BF-45002E7443AA","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"3d8506ccdb01239474b410accee92df4a7ced67f","datavalue":{"value":"10.48550/ARXIV.1909.03017","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q101301$908108DB-57DD-4A58-BFF4-07779514F60D","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Optimal curtailed designs for single arm phase II clinical trials","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/Optimal_curtailed_designs_for_single_arm_phase_II_clinical_trials"}}}}}